CIPO trademark

ZELWISPO

FiledCIPOWord markClass 5

"ZELWISPO" is a word mark owned by Bristol-Myers Squibb Company, filed at the CIPO on October 20, 2025. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).

View Bristol-Myers Squibb Company portfolioGet this data via the API
Official CIPO record
ZELWISPO
Word mark as filed with the CIPO
Status
Filed
Since June 17, 2026
Filed
October 20, 2025
Registered
Not yet
Priority date
June 27, 2025
Claimed from United States
Application no.
2431737
Registration no.
Not yet
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns ZELWISPO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Bristol-Myers Squibb Company

BMY · United States

1,822 trademarks in the portfolioView company

Representative

Gowling WLG (Canada) LLP

Gowling WLG (Canada) LLP

Goods and services

What the mark covers

The products and services ZELWISPO is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes.

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Examiner's First Report
  2. Search Recorded
  3. Pre-Assessment Letter Sent; Retired Goods or Services
  4. Formalized
  5. Created
  6. Filed
FAQ

About ZELWISPO

Who owns the trademark "ZELWISPO"?

The CIPO trademark "ZELWISPO" (application 2431737) is owned by Bristol-Myers Squibb Company.

What is the status of "ZELWISPO"?

Its status at the CIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ZELWISPO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019dee46-7895-70fd-9999-33e565ebcb5a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019dee46-7895-70fd-9999-33e565ebcb5a",
  "object": "trademark",
  "mark_text": "ZELWISPO",
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "CA",
  "application_number": "2431737",
  "filing_date": "2025-10-20",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Bristol-Myers Squibb Company",
      "entity_id": "ent_019f2853-4217-73ff-890d-eaf11eb9519e"
    }
  ]
}